Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial.
In conclusion, spironolactone reduces the acute increase in urinary oxidative stress in living-donor KT recipients.
PMID: 31241992 [PubMed - as supplied by publisher]
Source: Am J Physiol Renal P... - Category: Urology & Nephrology Authors: Morales-Buenrostro LE, Ortega Trejo JA, PĂ©rez-Villalva R, Marino LA, Gonzalez Bobadilla Y, Juarez H, Zamora Mejia FM, Gonzalez N, Espinoza R, Barrera-Chimal J, Bobadilla NA Tags: Am J Physiol Renal Physiol Source Type: research
More News: Corticosteroid Therapy | Kidney Transplant | Kidney Transplantation | Potassium | Prograf | Spironolactone | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology